BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,787,000 | -21.8% | 58,141 | -24.6% | 0.02% | -17.4% |
| Q2 2022 | $11,241,000 | -12.7% | 77,157 | -29.0% | 0.02% | +4.5% |
| Q1 2022 | $12,876,000 | +1.1% | 108,622 | +17.5% | 0.02% | +10.0% |
| Q4 2021 | $12,742,000 | +48.7% | 92,472 | +49.9% | 0.02% | +42.9% |
| Q3 2021 | $8,567,000 | +63.8% | 61,683 | +14.5% | 0.01% | +55.6% |
| Q2 2021 | $5,231,000 | +165.9% | 53,892 | +87.2% | 0.01% | +200.0% |
| Q1 2021 | $1,967,000 | -50.0% | 28,789 | -37.3% | 0.00% | -62.5% |
| Q4 2020 | $3,931,000 | -33.2% | 45,886 | -49.4% | 0.01% | -38.5% |
| Q3 2020 | $5,886,000 | +9.7% | 90,633 | +23.4% | 0.01% | +8.3% |
| Q2 2020 | $5,366,000 | +130.8% | 73,451 | +7.4% | 0.01% | +100.0% |
| Q1 2020 | $2,325,000 | +12.8% | 68,421 | +80.5% | 0.01% | +50.0% |
| Q4 2019 | $2,062,000 | +157.4% | 37,898 | +97.5% | 0.00% | +100.0% |
| Q3 2019 | $801,000 | +69.7% | 19,191 | +50.5% | 0.00% | +100.0% |
| Q4 2018 | $472,000 | +0.6% | 12,755 | +2.1% | 0.00% | 0.0% |
| Q3 2018 | $469,000 | -64.9% | 12,497 | -63.0% | 0.00% | -66.7% |
| Q2 2018 | $1,336,000 | +53.4% | 33,803 | 0.0% | 0.00% | +200.0% |
| Q1 2018 | $871,000 | +124.5% | 33,803 | +117.6% | 0.00% | 0.0% |
| Q2 2017 | $388,000 | – | 15,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |